ISSN 2639-9431
Vol. 1, Issue 1, 2018May 11, 2018 EDT
A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety test
A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety test
Articles in Vol. 1, Issue 1, 2018
Vol. 1, Issue 1, 2018
- A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety testJános SzebeniRudolf UrbanicsLászló DézsiPéter Bedőcs
- Origins to Outcomes: A Role for Extracellular Vesicles in Precision MedicineAdriele Prina-MelloCiaran Magus MaguireJohn Savage
- Discrepancies in the in vitro and in vivo role of scavenger receptors in clearance of nanoparticles by Kupffer cellsDmitri SimbergErnest GromanGuankui Wang
- Immunocompatibility of Rad-PC-Rad liposomes in vitro, based on human complement activation and cytokine releaseBert MüllerSofiya MatviykivGabriela GerganovaTamás MészárosGergely Tibor KozmaUte MettalFrederik NeuhausTakashi IshikawaJános SzebeniAndreas Zumbuehl
- Improving Innovation in Nano-Healthcare FundingMike Eaton
- Balancing Interests of Science, Scientists, and the Publishing BusinessLajos P Balogh
- The Story of Precision Nanomedicine – the JournalLajos Balogh
Szebeni, János, Rudolf Urbanics, László Dézsi, and Péter Bedőcs. 2018. “A Porcine Model of Complement Activation-Related Pseudoallergy to Nano-Pharmaceuticals: Pros and Cons of Translation to a Preclinical Safety Test.” Precision Nanomedicine 1 (1): 63–73. https://doi.org/10.29016/180427.1.